Prescription drug · ANDA
Estradiol NDC 72162-2293
Estradiol 1 mg/g · Gel · Topical · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72162-2293-3 | 72162229303 | 30 PACKET in 1 CARTON (72162-2293-3) / 1 g in 1 PACKETMarketed from Apr 30, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Estradiol
- Generic name (nonproprietary)
- estradiol
- Active ingredients
- Estradiol — 1 mg/g
- Dosage form
- Gel
- Route
- Topical
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 216524
- Marketing start
- Listing expires
- Other FDA classes
- Estradiol Congeners (Chemical structure)Estrogen Receptor Agonists (Mechanism)
- Identifiers
- Product ID 72162-2293_23bb5d4c-7b83-4621-bb3b-357952c55130SPL ID 23bb5d4c-7b83-4621-bb3b-357952c55130SPL set ID 0e927450-3f02-4d2f-9235-a255357e8d93RxCUI 2619683UNII 4TI98Z838E
- Pharmacologic class
- Estrogen
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472162229303followed by a unit qualifier and the quantityPackage 72162-2293-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Estradiol gel is an estrogen indicated for the treatment of moderate to severe vasomotor symptoms due to menopause ( 1.1 ). 1.1 Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 216524
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Estradiol | Estradiol .25 mg/.25g | GelTopical | Bryant Ranch Prepack | 72162-2290 |
| Estradiol | Estradiol .5 mg/.5g | GelTopical | Bryant Ranch Prepack | 72162-2291 |
| Estradiol | Estradiol .75 mg/.75g | GelTopical | Bryant Ranch Prepack | 72162-2292 |
| Estradiol | Estradiol .25 mg/.25g | GelTopical | Padagis Israel Pharmaceuticals Ltd | 45802-134 |
| Estradiol | Estradiol .5 mg/.5g | GelTopical | Padagis Israel Pharmaceuticals Ltd | 45802-202 |
| Estradiol | Estradiol .75 mg/.75g | GelTopical | Padagis Israel Pharmaceuticals Ltd | 45802-310 |
| Estradiol | Estradiol 1 mg/g | GelTopical | Padagis Israel Pharmaceuticals Ltd | 45802-452 |
| Estradiol | Estradiol 1.25 mg/1.25g | GelTopical | Padagis Israel Pharmaceuticals Ltd | 45802-573 |
- openFDA data updated
Med-Code stores this record for up to 24 hours before requesting it again.
Reference information only. Verify codes and billing rules against the applicable payer and official source before submitting a claim. How Med-Code handles data.